Table 4.
The results of the two-piecewise linear regression model
| AGR | No. of participants | Hazard ratio (95% CIs) | p-value |
|---|---|---|---|
| Fitting model by standard linear regression | 196 | 0.60 (0.26, 1.36) | 0.2191 |
| Fitting model by two-piecewise linear regression | |||
| ≤ 1.24 | 41 | 13.05 (0.52, 327.64) | 0.1183 |
| > 1.24 | 155 | 0.20 (0.07, 0.57) | 0.0025 |
| p for log-likelihood ratio test | 0.0240 |
Adjusted for: Age; Gender; Never smoker; Hypertension; ALK rearrangement; EGFR mutation; Histology; Tumor stage; ECOG PS score; Number of metastases; Number of previous treatment lines; Number of previous chemotherapy lines; Previous targeted therapy; Previous radiotherapy; Previous immunotherapy; Anlotinib monotherapy; Leukocyte; Neutrophil; Lymphocyte; Platelets. Restricted cubic spline was applied